408 related articles for article (PubMed ID: 28429185)
1. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.
Conant G; Lai BFL; Lu RXZ; Korolj A; Wang EY; Radisic M
Stem Cell Rev Rep; 2017 Jun; 13(3):335-346. PubMed ID: 28429185
[TBL] [Abstract][Full Text] [Related]
2. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic cell chips for high-throughput drug screening.
Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
[TBL] [Abstract][Full Text] [Related]
4. From cardiac tissue engineering to heart-on-a-chip: beating challenges.
Zhang YS; Aleman J; Arneri A; Bersini S; Piraino F; Shin SR; Dokmeci MR; Khademhosseini A
Biomed Mater; 2015 Jun; 10(3):034006. PubMed ID: 26065674
[TBL] [Abstract][Full Text] [Related]
5. Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.
Park J; Wu Z; Steiner PR; Zhu B; Zhang JXJ
Ann Biomed Eng; 2022 Feb; 50(2):111-137. PubMed ID: 35039976
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular human organ-on-a-chip platform for disease modeling, drug development, and personalized therapy.
Khanna A; Oropeza BP; Huang NF
J Biomed Mater Res A; 2024 Apr; 112(4):512-523. PubMed ID: 37668192
[TBL] [Abstract][Full Text] [Related]
7. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
Cavero I; Guillon JM; Holzgrefe HH
Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
[TBL] [Abstract][Full Text] [Related]
8. Organs-on-chips at the frontiers of drug discovery.
Esch EW; Bahinski A; Huh D
Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
[TBL] [Abstract][Full Text] [Related]
9. Engineered platforms for mimicking cardiac development and drug screening.
Stiefbold M; Zhang H; Wan LQ
Cell Mol Life Sci; 2024 Apr; 81(1):197. PubMed ID: 38664263
[TBL] [Abstract][Full Text] [Related]
10. Heart-on-a-chip systems: disease modeling and drug screening applications.
Butler D; Reyes DR
Lab Chip; 2024 Feb; 24(5):1494-1528. PubMed ID: 38318723
[TBL] [Abstract][Full Text] [Related]
11. Human iPSC-based cardiac microphysiological system for drug screening applications.
Mathur A; Loskill P; Shao K; Huebsch N; Hong S; Marcus SG; Marks N; Mandegar M; Conklin BR; Lee LP; Healy KE
Sci Rep; 2015 Mar; 5():8883. PubMed ID: 25748532
[TBL] [Abstract][Full Text] [Related]
12. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
[TBL] [Abstract][Full Text] [Related]
13. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
Wang YI; Carmona C; Hickman JJ; Shuler ML
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
[TBL] [Abstract][Full Text] [Related]
14. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
15. Organ-on-chip models: Implications in drug discovery and clinical applications.
Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.
Portillo-Lara R; Spencer AR; Walker BW; Shirzaei Sani E; Annabi N
Biomaterials; 2019 Apr; 198():78-94. PubMed ID: 30201502
[TBL] [Abstract][Full Text] [Related]
17. Introducing an automated high content confocal imaging approach for Organs-on-Chips.
Peel S; Corrigan AM; Ehrhardt B; Jang KJ; Caetano-Pinto P; Boeckeler M; Rubins JE; Kodella K; Petropolis DB; Ronxhi J; Kulkarni G; Foster AJ; Williams D; Hamilton GA; Ewart L
Lab Chip; 2019 Jan; 19(3):410-421. PubMed ID: 30663729
[TBL] [Abstract][Full Text] [Related]
18. Human-Derived Organ-on-a-Chip for Personalized Drug Development.
Jodat YA; Kang MG; Kiaee K; Kim GJ; Martinez AFH; Rosenkranz A; Bae H; Shin SR
Curr Pharm Des; 2018; 24(45):5471-5486. PubMed ID: 30854951
[TBL] [Abstract][Full Text] [Related]
19. Towards chamber specific heart-on-a-chip for drug testing applications.
Zhao Y; Rafatian N; Wang EY; Wu Q; Lai BFL; Lu RX; Savoji H; Radisic M
Adv Drug Deliv Rev; 2020; 165-166():60-76. PubMed ID: 31917972
[TBL] [Abstract][Full Text] [Related]
20. A Bioprinted Liver-on-a-Chip for Drug Screening Applications.
Knowlton S; Tasoglu S
Trends Biotechnol; 2016 Sep; 34(9):681-682. PubMed ID: 27291461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
